SEC Form 4 · accession 0001209191-16-133601
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Jul 19, 2016
Accepted (ET)
Jul 21, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 19, 2016 | S | 857 | $45.40 | D | 4,656 | D | |
| Common StockF3 | Jul 20, 2016 | S | 1,849 | $44.8521 | D | 2,807 | D | |
| Common StockF4 | Jul 20, 2016 | S | 101 | $45.3351 | D | 2,706 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- F2This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.
- F3The range in prices for the transaction reported on this line was $44.30 to $45.30. The average weighted price was $44.8521. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range in prices for the transaction reported on this line was $45.32 to $45.35. The average weighted price was $45.3351. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.